417 related articles for article (PubMed ID: 26165843)
1. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.
Deguchi A; Tomita T; Omori T; Komatsu A; Ohto U; Takahashi S; Tanimura N; Akashi-Takamura S; Miyake K; Maru Y
J Immunol; 2013 Aug; 191(4):1856-64. PubMed ID: 23858030
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
[TBL] [Abstract][Full Text] [Related]
4. S100A8 contributes to postoperative cognitive dysfunction in mice undergoing tibial fracture surgery by activating the TLR4/MyD88 pathway.
Lu SM; Yu CJ; Liu YH; Dong HQ; Zhang X; Zhang SS; Hu LQ; Zhang F; Qian YN; Gui B
Brain Behav Immun; 2015 Feb; 44():221-34. PubMed ID: 25449673
[TBL] [Abstract][Full Text] [Related]
5. Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling.
Ye K; Chen QW; Sun YF; Lin JA; Xu JH
J Cell Biochem; 2018 Feb; 119(2):1922-1930. PubMed ID: 28815730
[TBL] [Abstract][Full Text] [Related]
6. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
7. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
8. Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
Liu H; Zhang G; Huang J; Ma S; Mi K; Cheng J; Zhu Y; Zha X; Huang W
J Transl Med; 2016 Apr; 14(1):104. PubMed ID: 27118139
[TBL] [Abstract][Full Text] [Related]
9. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions.
Okada K; Arai S; Itoh H; Adachi S; Hayashida M; Nakase H; Ikemoto M
J Leukoc Biol; 2016 Nov; 100(5):1093-1104. PubMed ID: 27312849
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
Rallabhandi P; Phillips RL; Boukhvalova MS; Pletneva LM; Shirey KA; Gioannini TL; Weiss JP; Chow JC; Hawkins LD; Vogel SN; Blanco JC
mBio; 2012; 3(4):. PubMed ID: 22872782
[TBL] [Abstract][Full Text] [Related]
11. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
[TBL] [Abstract][Full Text] [Related]
13. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells.
Kwon CH; Moon HJ; Park HJ; Choi JH; Park DY
Mol Cells; 2013 Mar; 35(3):226-34. PubMed ID: 23456298
[TBL] [Abstract][Full Text] [Related]
14. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
15. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase.
Hiratsuka S; Watanabe A; Sakurai Y; Akashi-Takamura S; Ishibashi S; Miyake K; Shibuya M; Akira S; Aburatani H; Maru Y
Nat Cell Biol; 2008 Nov; 10(11):1349-55. PubMed ID: 18820689
[TBL] [Abstract][Full Text] [Related]
16. S100A8 may govern hyper-inflammation in severe COVID-19.
Deguchi A; Yamamoto T; Shibata N; Maru Y
FASEB J; 2021 Sep; 35(9):e21798. PubMed ID: 34339064
[TBL] [Abstract][Full Text] [Related]
17. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans induces the expression of chemokines MCP-1, MIP-1α, and IP-10 via similar but distinct signaling pathways in murine macrophages.
Park OJ; Cho MK; Yun CH; Han SH
Immunobiology; 2015 Sep; 220(9):1067-74. PubMed ID: 26003840
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury.
Shimamoto A; Chong AJ; Yada M; Shomura S; Takayama H; Fleisig AJ; Agnew ML; Hampton CR; Rothnie CL; Spring DJ; Pohlman TH; Shimpo H; Verrier ED
Circulation; 2006 Jul; 114(1 Suppl):I270-4. PubMed ID: 16820585
[TBL] [Abstract][Full Text] [Related]
20. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
Kim JH; Oh SH; Kim EJ; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
Biochem Biophys Res Commun; 2012 Jun; 423(1):60-6. PubMed ID: 22634002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
